Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised application seeking full approval of the shot for adults ages 50 to 64, and ...
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Questions about the COVID-19 shot abound as federal recommendations shift and medical groups issue clashing guidance.
By Nate Raymond, Ahmed Aboulenein and Leah Douglas BOSTON, March 16 (Reuters) - A federal judge on Monday blocked key parts of Health Secretary Robert F. Kennedy Jr.'s effort to reshape U.S. vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results